Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age
Clinical trial NCT00397215 · COMPLETED
Trial details
- NCT number
- NCT00397215
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-17
- Primary completion
- 2009-09-14
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.